[[Study of Tamoxifen and Raloxifene]]

CATEGORIES: Breast cancer, Chemotherapy

The Study of Tamoxifen and Raloxifene (STAR) is a clinical trial designed determine how the drug raloxifene compares with the drug tamoxifen in reducing the incidence of breast cancer in women who are at increased risk of the disease.[tpl]cite web | title=Study of Tamoxifen and Raloxifene (STAR) | publisher=Weill Cornell Medical College | url=http://www.cornellsurgery.org/patients/health/breast_star.html [/tpl]

==Research==

One of the largest breast cancer prevention studies ever,"Osteoporosis drug equals tamoxifen in preventing breast cancer", Pittsburgh Post-Gazette, April 18, 2006 it included 22,000 women in 400 medical centers in the United States and Canada."Drug Slashes Breast Cancer Risk, Study Shows", New York Times, June 16, 1999[tpl]cite web | author=Wickerham L | title=What is the Study of Tamoxifen and Raloxifene Breast Cancer Prevention Trial? | publisher=ABC News | url=http://abcnews.go.com/Health/OnCallPlusTreatment/study-tamoxifen-raloxifene-breast-cancer-prevention-trial/story?id=3656322#.Twxa5oE2yuI [/tpl][tpl]cite web | title=Study of Tamoxifen and Raloxifene (STAR) | publisher=Columbia St. Mary's | url=http://www.columbia-stmarys.org/stw/Page.asp?PageID=STW037333 [/tpl]
The study concluded that raloxifene caused fewer side-effects and less endometrial cancer than tamoxifen.[tpl]cite web | title=Teleconference: Study of Tamoxifen and Raloxifene (STAR) P-2 | publisher=American Association for Cancer Research | url=http://aacrnews.wordpress.com/2010/04/19/teleconference-study-of-tamoxifen-and-raloxifene-star-p-2/ [/tpl]"Raloxifene or tamoxifen: Which is the right drug for you?", USA Today, April 17, 2006 Raloxifene was found to be more effective at preventing noninvasive breast cancer but less effective at preventing invasive breast cancer."Raloxifene, Tamoxifen Both Guard Against Breast Cancer", Business Week, April 19, 2010

==References==

==External links==


